Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Danske Markets, Handelsbanken, Nordea and SEB in connection with Billerud's rights issue
Mandate

Vinge advises Danske Markets, Handelsbanken, Nordea and SEB in connection with Billerud's rights issue

July 27, 2009

Vinge has advised a consortium of banks consisting of Danske Markets, Nordea, Handelsbanken and SEB in connection with Billerud's rights issue of a total of approximately SEK 1000 million with pre-emption rights for Billerud's existing shareholders. The issue is fully guaranteed by Billerud's principal shareholders and the banking consortium. Billerud is listed on NASDAQ OMX Stockholm.
 
Ola Sandersson and Dain Nevonen advised the banking consortium

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026